The estimated Net Worth of Linda Rhodes is at least $3.85 Million dollars as of 21 May 2024. Linda Rhodes owns over 2,441 units of Zoetis Inc stock worth over $2,229,153 and over the last 17 years he sold ZTS stock worth over $1,288,007. In addition, he makes $330,000 as Independent Director at Zoetis Inc.
Linda has made over 23 trades of the Zoetis Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 2,441 units of ZTS stock worth $463,766 on 21 May 2024.
The largest trade he's ever made was selling 20,000 units of Zoetis Inc stock on 6 March 2015 worth over $400,000. On average, Linda trades about 2,472 units every 172 days since 2007. As of 21 May 2024 he still owns at least 11,733 units of Zoetis Inc stock.
You can see the complete history of Linda Rhodes stock trades at the bottom of the page.
Dr. Linda Rhodes Ph.D. serves as Independent Director of the Company. Dr. Rhodes served as Chief Scientific Officer of Aratana Therapeutics from 2012 to 2016 and served as its Chief Executive Officer and Board member from 2011 to 2012. Dr. Rhodes has extensive experience as a research scientist, academic, veterinary practitioner and business leader, spanning nearly 30 years across the animal health industry. She is a founder of AlcheraBio, LLC, a veterinary contract research organization, and held various research positions with Merial, Merck and Company, and Sterling-Winthrop Drug Company. Dr. Rhodes also held several teaching positions and worked as a bovine veterinarian in private practice for many years. Dr. Rhodes served as a member of the Board of Directors of ImmuCell Corporation from 2005 until 2017. She is currently an adjunct faculty member of the Graduate Program in Endocrinology and Animal Biosciences at Rutgers University in New Brunswick, New Jersey. She serves on the Scientific Advisory Board of the Found Animals Foundation and on the Board of Directors of the Alliance for Contraception in Cats and Dogs. Dr. Rhodes earned her Ph.D. in Physiology from Cornell University and her VMD from the University of Pennsylvania. Dr. Rhodes’ experience as a research scientist, academic, veterinary practitioner, entrepreneur and business leader, her public company board experience and her knowledge of the animal health business make her a valuable member of our Board.
As the Independent Director of Zoetis Inc, the total compensation of Linda Rhodes at Zoetis Inc is $330,000. There are 11 executives at Zoetis Inc getting paid more, with Glenn David having the highest compensation of $3,672,350.
Linda Rhodes is 70, he's been the Independent Director of Zoetis Inc since 2017. There are 1 older and 21 younger executives at Zoetis Inc. The oldest executive at Zoetis Inc is William Steere, 83, who is the Independent Director.
Linda's mailing address filed with the SEC is C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY, NJ, 07054.
Over the last 12 years, insiders at Zoetis Inc have traded over $876,669,659 worth of Zoetis Inc stock and bought 1,602,140 units worth $77,083,975 . The most active insiders traders include Square Capital Management, ..., Frank A Damelio, and Michael B Mccallister. On average, Zoetis Inc executives and independent directors trade stock every 14 days with the average trade being worth of $14,414,921. The most recent stock trade was executed by Soria Ester Banque on 31 July 2024, trading 895 units of ZTS stock currently worth $170,041.
Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.
Zoetis Inc executives and other stock owners filed with the SEC include: